Modera Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$956K Buy
6,102
+1,177
+24% +$176K 0.01% 355
2026
Q1
$752K Sell
4,925
-473
-9% -$72.5K 0.01% 366
2025
Q4
$744K Buy
5,398
+141
+3% +$18.5K 0.01% 382
2025
Q3
$674K Buy
5,257
+2
+0% +$244 0.01% 403
2025
Q2
$636K Sell
5,255
-146
-3% -$16.5K 0.01% 404
2025
Q1
$602K Sell
5,401
-375
-6% -$39.9K 0.01% 398
2024
Q4
$562K Buy
5,776
+341
+6% +$36.4K 0.01% 414
2024
Q3
$625K Buy
5,435
+150
+3% +$17K 0.01% 375
2024
Q2
$563K Sell
5,285
-2,464
-32% -$247K 0.01% 377
2024
Q1
$750K Sell
7,749
-30
-0.4% -$3.08K 0.01% 336
2023
Q4
$785K Buy
7,779
+223
+3% +$21.5K 0.01% 316
2023
Q3
$770K Buy
7,556
+98
+1% +$9.95K 0.01% 308
2023
Q2
$753K Buy
7,458
+3,200
+75% +$320K 0.01% 320
2023
Q1
$392K Sell
4,258
-600
-12% -$52.4K 0.02% 247
2022
Q4
$441K Buy
4,858
+660
+16% +$55.6K 0.02% 227
2022
Q3
$319K Sell
4,198
-188
-4% -$15.6K 0.02% 234
2022
Q2
$371K Buy
4,386
+136
+3% +$11.9K 0.02% 230
2022
Q1
$373K Buy
+4,250
New +$368K 0.02% 246
2021
Q2
Sell
-3,039
Closed -$260K 246
2021
Q1
$260K Buy
3,039
+761
+33% +$68.3K 0.02% 190
2020
Q4
$215K Buy
+2,278
New +$199K 0.02% 219

Other funds holding NVS

Modera Wealth Management's NVS Position: Q2 2026 in Review

Modera Wealth Management increased its Novartis (NVS) stake by 24% in Q2 2026, buying an estimated $176K and bringing the position to 6,102 shares worth $956K. The position accounts for 0.01% of the portfolio, ranked #355.

Modera Wealth Management first reported a position in NVS in Q4 2020 and has held it in 20 quarters since. 1,027 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Modera Wealth Management held 6,102 shares of Novartis worth $956K as of Q2 2026.
  • Modera Wealth Management bought 1,177 Novartis shares in Q2 2026, an estimated $176K.
  • Novartis made up 0.01% of Modera Wealth Management's portfolio in Q2 2026, its #355 holding.
  • Modera Wealth Management first reported a position in Novartis in Q4 2020 and has held it in 20 quarters since.
  • 1,027 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Modera Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.